Full text is available at the source.
Abstract
The increased utilization of medication microdosing is a response to the high demand and limited supply of GLP-1 receptor agonists (GLP-1 RAs).
- GLP-1 is an endocrine hormone that helps lower blood glucose levels and supports weight loss.
- GLP-1 receptor agonists are synthetic peptides designed to mimic the effects of GLP-1.
- There is a significant demand for GLP-1 RA medications, leading to high costs and care gaps for patients.
- The shortage of GLP-1 RAs has prompted healthcare providers to adopt creative treatment strategies.
- Long-term microdosing of GLP-1 RAs may offer potential benefits, though this area requires further investigation.
Simplified